{"entity":{"id":"nct07764653","kind":"trial","name":"Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer","aka":[],"tldr":"A phase 3 trial of Technetium Tc-99m sulfur colloid in Breast cancer, run by HTA Co., Ltd., completed.","summary":"Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer is a phase 3 interventional study registered as NCT07764653 by HTA Co., Ltd., with 213 participants recorded, started 2024-01-02 and reaching its primary completion in 2025-06-03. Interventions recorded: Technetium Tc 99m Sulfur Colloid Injection, Mitoxantrone Hydrochloride Injection for Tracing. Conditions recorded: Sentinel Nodes, Breast Cancer.\n\nLinked to the drug Technetium Tc-99m sulfur colloid because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT07764653","url":"https://clinicaltrials.gov/study/NCT07764653"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["breast-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":["technetium-sulfur-colloid"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07764653","phase":"3","setting":"Efficacy and Safety of Technetium Tc 99m Sulfur Colloid Injection for Tracing Sentinel Nodes in Breast Cancer: A Self-Controlled Clinical Trial","sponsor":"HTA Co., Ltd.","enrolled":213,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07764653/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"}],"drug":[{"id":"technetium-sulfur-colloid","kind":"drug","name":"Technetium Tc-99m sulfur colloid","route":"/drugs/technetium-sulfur-colloid/"}]}}